Manufacturing Control Setup
At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its wide-ranging issues from complex research development and regulatory conditions to rapidly changing consumer demands. Our Generics portfolio offers over 1500 products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum, Benacof, Wallbrurate, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other countries. Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the world. We have capitalized on every opportunity to bring our high-quality products to more people around the world. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing and vertical integration with our own APIs has created a creditable track record of successful launches. Our generics offerings deliver quality at cost-effective prices in the highly regulated markets of the United States, UK and other Asian countries.
At Taj Ando, we have eight manufacturing sites situated worldwide. Our state of the art facilities have international accreditation such as WHO, TGA, GMP certification and US FDA approval.
Some of the key features of our facility include:
1- A modern quality assurance, quality control, microbiological and PD Laboratory with the latest high tech equipment.
2- Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines.
3- Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines.
4- Sophisticated Effluent Treatment Plant (ETP) with a capacity of 100,000 litres per day.
5- Conforms to international environmental, health & safety regulations.
Research and Development
Our state of the art R&D facilities have developed several products over the past 20 years. Our R&D staff compliment consist of highly qualified individuals, who have in depth knowledge and experience in all areas of pharmaceutical R&D. The main objective of our R&D team is the development of safe, cost effective and high quality products.
Our facilities have been inspected by several regulatory bodies for compliance and have received successful reports and approvals from both international and local regulatory bodies. The approvals from international regulatory bodies are especially important as it enables us to conduct important clinical trials for the development of innovative products and APIs. We have development products across a wide spectrum of therapeutic areas.
Our R&D facilities, together with our experienced clinical research team, have the capacity to assist other pharmaceutical companies in conducting:
- Clinical trials
- Quality Control Tests
- Drug Analysis
- Safety Control Tests
Taj Pharma is one of the leading generic and branded pharmaceutical manufacturing company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets. We have eight manufacturing sites in India to support our market standing, holding a strong regulatory position and major certifications for most markets. Today, we market more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
Copyright 2014 Taj Pharmaceuticals Limited. All rights reserved.Taj Pharma Group India.
Neogra® is Registered Trade Mark of Taj Pharma India 2009-2014